Total intravenous anaesthesia with propofol is commonly used for thoracic surgical procedures. With target-controlled infusion (TCI), a pharmacokinetic model is used by a computer program to adjust the rate of delivery of propofol. This form of anaesthesia delivery requires predictable drug pharmacokinetics.
Total intravenous anaesthesia with propofol is commonly used for thoracic surgical procedures. With target-controlled infusion (TCI), a pharmacokinetic model is used by a computer program to adjust the rate of delivery of propofol. This form of anaesthesia delivery requires predictable drug pharmacokinetics.
It is feasible that propofol elimination pharmacokinetics could be altered during some surgical procedures. Propofol metabolism occurs in the liver and kidneys 1 and propofol is sequestered in the lungs 2, 3 . Open-chest surgery in the lateral position may be expected to alter renal, hepatic and pulmonary perfusion through several mechanisms, including gravity-induced alterations in blood flow through the dependent and non-dependent pulmonary circulations, movement of abdominal contents into the non-dependent hemithorax, surgical retraction of thoracic organs, alterations in cardiac output during the procedure and through activation of the sympathetic nervous system. It is possible that this may result in unpredictable blood concentrations of propofol during TCI infusion of propofol. There is little information available on the use of propofol TCI under these circumstances.
Our study hypothesis is that open-chest surgery in the lateral position increases the blood concentration of propofol during TCI.
SUMMARy
Our research hypothesis was that single lung ventilation during thoracic surgery in the lateral position increases the blood concentration of propofol during target-controlled infusion.
Thirty adult patients in two tertiary referral hospitals undergoing open-chest surgery were studied. Anaesthesia was induced and maintained with propofol using a Diprifusor (Graseby 3500) computer-controlled pump set to deliver a blood concentration of 4 µg.ml -1 . Blood samples were taken with the patient positioned in 1) the supine position 20 minutes after induction (supine); 2) the lateral position just prior to one-lung ventilation (lateral); 3) the lateral position five minutes after commencing one-lung ventilation (OLV5) and 4) the lateral position 20 minutes after commencing one-lung ventilation (OLV20). Propofol concentrations were determined by high performance liquid chromatography.
The target-controlled infusion target level was maintained at 4 µg.ml -1 during the study period for all cases. The mean (SD) propofol blood concentration (µg.ml -1 ) at each stage was 5.5 (1.5) supine, 5.3 (1.1) lateral, 5.3 (1.2) OLV5 and 5.1 (1.2) OLV20. Repeated measures ANOVA showed an F value 1.9, lambda 5.5 and P value 0.15. Post hoc analysis did not identify a significant difference between the sample times.
During target-controlled infusion of propofol, mean blood propofol concentrations did not change significantly from those obtained with the patient supine after up to 50 minutes in the lateral position during thoracic surgery, or 20 minutes after commencing one-lung ventilation. 
METHOD
Institutional Ethics Committee approval was obtained from Royal Perth Hospital and Sir Charles Gairdner Hospital. Subjects gave written informed consent. To be included in the study, patients were required to undergo an elective thoracic procedure requiring lateral positioning and one-lung ventilation. Patients were excluded if they had an ASA physical status greater than II, were aged greater than 80 or less than 18 years; had a body mass index greater than 35 kg.m -2 ; were identified as having a risk of aspiration or difficult tracheal intubation, or if they had any of the following conditions: symptomatic ischaemic heart disease, pregnancy, liver disease, allergy to propofol, opioid tolerance or previous anaesthetic awareness.
Patients were premedicated as necessary with oral temazepam 20 to 30 mg. After cannulation of the radial artery and the application of bispectral index monitoring, patients were preoxygenated for three minutes and had general anaesthesia induced with fentanyl 2 µg.kg -1 and a propofol TCI infusion started at a predicted blood concentration of 4 µg.ml -1 . A Graseby 3500 infusion pump (Smiths Medical, Watford, Uk) with a Diprifusor TCI program (AstraZeneca, London, Uk) was used for all cases. The Diprifusor uses the Marsh algorithm for estimation of blood propofol concentration.
The left main bronchus was intubated with a double-lumen tube (Mallinckrodt Healthcare, Hazelwood, MO, USA). The position was checked with a fibreoptic bronchoscope. At this time, clamping of either lumen of the double-lumen tube was limited to less than five seconds. No patients had epidural analgesia. Injection of paravertebral or intercostal local analgesia was performed after the last blood sample had been taken.
Anaesthesia was maintained with a propofol TCI at a target blood concentration of 4 µg.ml -1 . Inadequate anaesthesia, defined as an increase in heart rate or blood pressure more than 20% of baseline, or a BIS value greater than 60, was to be treated with bolus doses of fentanyl 50 µg to a maximum dose of 7 µg.kg -1 . If this limit was reached, an increase in the target blood concentration was permitted. Suggestion of excessive depth of anaesthesia (mean arterial blood pressure less than 20% of baseline) was to be treated by increasing the rate of crystalloid infusion and 500 µg metaraminol boluses. If these interventions did not restore the blood pressure to the acceptable level, a decrease in the target TCI blood concentration was permitted.
Assays of propofol concentration were made from arterial blood samples taken from the radial arterial cannula. Samples were stored in a glass tube with EDTA anticoagulant on ice until the study protocol for each patient was completed. On arrival in the laboratory, the samples were stored at minus 40°C until analysis. After extraction of the samples according to the procedure of Chan and So 4 , the samples were analysed by high performance liquid chromatography (HPLC). The HPLC conditions included a Merk LiChrospher RP select B column, with a solvent of 60% acetonitrile in 45nM kH 2 PO 4 (previously adjusted to pH 3.0 with phosphoric acid) run at 1.3 ml.min -1 , with quantitation effected by absorption at 270 nm.
Blood samples were taken at the following stages: with the patient in the supine position 20 minutes after induction (supine); in the lateral position, just before the onset of one-lung ventilation (lateral); five minutes after the onset of one-lung ventilation (OLV5) and 20 minutes after the onset of one-lung ventilation (OLV20).
For each measured blood concentration, the performance error was calculated according to the recommendations of Varvel and co-workers 5 : (CM-CCALC)/CCALC, where CM and CCALC are the measured and calculated blood propofol concentrations, respectively.
It was anticipated 6 that the standard deviation of measured blood concentration of propofol would be 1.4 µg.ml -1 . Using repeated measures ANOVA, with an alpha of 0.05 and a beta of 0.2, it was estimated that 25 subjects would be required to detect a difference of 1 µg.ml -1 . Normally distributed data were described with mean and standard deviation, and other data as median and interquartile range (IQR). The hypothesis was tested with repeated measures ANOVA using a Bonferroni post hoc analysis to compare mean differences in concentration between samples.
RESULTS
Thirty subjects (18 male) were studied. The subjects had a median (IQR) weight of 76 (17.5) kg, body mass index of 26.6 (3.7) and age of 58.5 (18) years. Twenty-two patients underwent surgery requiring thoracotomy and eight patients had video-assisted thoracotomy using thoracoscopic instruments. Twenty subjects had known or suspected lung malignancies, three had suspected pleural malignancies, one had a paravertebral tumour and six had non-malignant disease. Fifteen subjects had right-sided surgery. Twenty subjects were studied at Sir Charles Gairdner Hospital and 10 at Royal Perth Hospital.
All patients were given propofol TCI at a predicted blood concentration of 4 µg.ml -1 throughout the study period. All four samples were obtained for 29 patients, but one patient required pulmonary deflation for less than 20 minutes and sample 4 could not be obtained. The median (IQR) time, in minutes, after induction when the samples were taken for the first, second, third and fourth samples respectively were 20 (11) , 51 (15), 62 (17) and 79 (24). The third sample was taken 32 (19) minutes after turning into the lateral position, 5.5 (1) minutes after the institution of one-lung ventilation and four (3) minutes after opening the chest. The fourth sample was taken 22 (2.5) minutes after deflating the operative lung. Twenty subjects had a fall in mean arterial blood pressure of greater than 20%, which was treated with a mean of 1.7 mg of metaraminol and 1 litre of crystalloid infusion. No patient had the operative pulmonary artery clamped during the study period. No patient required a change of target blood propofol level during the study.
The arterial blood propofol concentrations for each subject are displayed in Figure 1 . The mean (SD) propofol blood concentration (µg.ml -1 ) at each stage was 5.5 (1.5) supine, 5.3 (1.1) lateral, 5.3 (1.2) OLV5 and 5.1 (1.2) OLV20. Repeated measures ANOVA showed an overall F value 1.9, lambda 5.5 and P value 0.15. Post hoc analysis showed no significant difference between the groups. The greatest difference was observed between the supine and OLV20 samples, the mean difference being -0.48 µg/ml (95% confidence interval +0.10 to -1.06 µg.ml -1 , P=0.022, with a P value of 0.008 required for significance at an alpha of 0.05).
Ninety-five percent of all samples measured had a propofol concentration between 3.2 and 8.2 µg.ml -1 . The propofol concentrations measured in each patient are graphed against time since the start of infusion in Figure 1 . The median performance error (MDPE) was 29%.
DISCUSSION
We have found that one-lung ventilation during thoracic surgery in the lateral position does not significantly affect the blood concentration of propofol during stable target-controlled infusion of propofol. There is evidence that propofol is eliminated by the liver and kidneys. Hiraoka and co-workers 1 measured blood concentrations in the radial artery and renal, hepatic and pulmonary veins in six patients undergoing cardiac surgery who were given a continuous infusion of propofol at 4 mg.kg -1 .min -1 , they estimated the hepatic extraction ratio was 0.87 and the renal extraction ratio was 0.7. Takizawa and co-workers 7 measured renal vein propofol concentration in 10 patients undergoing nephrectomy and estimated that renal extraction of propofol was 0.6. Our results would imply that there are no significant changes to renal and hepatic metabolism of propofol during open chest surgery in the lateral position.
There has been considerable interest in the possibility of pulmonary elimination of propofol. Initial animal studies demonstrated pulmonary sequestration of propofol after a single bolus injection: kuipers and co-workers 2 demonstrated pulmonary uptake in a sheep model, and Matot and co-workers 3 demonstrated pulmonary uptake of propofol in cats. Similar sequestration has been observed in humans by He and co-workers 8 after a single bolus of propofol, however during a subanaesthetic infusion (50 µg.kg -1 .min -1 ), radial and pulmonary artery concentrations of propofol were found to be identical. Chen and associates 9 studied 15 patients undergoing liver transplantation who were given a constant infusion of propofol at 2 mg.kg -1 .h -1 and demonstrated minimal differences between pulmonary artery and radial artery concentration of propofol. Hirakoa and co-workers 1 also demonstrated minimal extraction of propofol from the lungs during steady-state infusion.
We observed a MDPE of 29%, which is reflected in the higher than expected propofol levels we observed at all observation points. Previous observers have made various estimates of performance error. Swinhoe and co-workers 10 observed a MDPE of 16% in adult patients undergoing major surgery, Li and co-workers 11 observed a MDPE of 15% in adult Chinese patients undergoing prolonged abdominal surgery, Hoymork and co-workers 12 observed a MDPE of 60% in patients undergoing laparoscopic cholecystectomy with co-infusion of remifentanil, attributing their results to reduced metabolism of propofol. We cannot determine whether the performance error observed in our patients reflects reduced propofol metabolism, as we did not observe a comparative group undergoing non-thoracic surgery in the supine position.
We measured the blood concentration of propofol for 49 minutes after turning the subject into the lateral position, but only the first 20 minutes of one-lung ventilation and 19 minutes after opening the chest wall. Data presented by Schuttler and coworkers 13 suggests that the time to 50% change in propofol concentration after a step change in administration was close to 20 minutes. It is possible that blood concentration changes greater than those we observed could occur during one-lung ventilation for more than 20 minutes.
The present study does not support the hypothesis that one-lung ventilation in the lateral position during thoracic surgery alters propofol blood concentration during constant target-controlled infusion. We have demonstrated it is unnecessary to make alterations to the TCI algorithm, at least during the first 20 minutes of one-lung ventilation.
